Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-01-01
著者
-
NICKOLOFF Brian
Department of Pathology, Cardinal Bernardin Cancer Center, Loyola University of Chicago
-
Qin Jian-zhong
Department Of Pathology Loyola University Medical Center
-
Chaturvedi Vijaya
Department Of Pathology Loyola University Medical Center
-
BODNER Barbara
Department of Pathology, Loyola University Medical Center
-
Bodner Barbara
Department Of Pathology Loyola University Medical Center
-
Nickoloff Brian
Department Of Pathology And Skin Cancer Research Laboratories Cardinal Bernardin Cancer Center Loyol
関連論文
- Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions
- Abnormal NF-κB signaling pathway with enhanced susceptibility to apoptosis in immortalized keratinocytes
- Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway
- Chemokine and inflammatory cytokine changes during chronic wound healing
- Injection of human herpesvirus-8 in human skin engrafted on SCID mice induces Kaposi's sarcoma-like lesions
- Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system
- Senescent human keratinocytes suppress colony formation of HeLa cells
- Dermatofibroma and dermatofibrosarcoma protuberans : an immunohistochemical study reveals distinctive antigenic profiles
- Targeting TNFα rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation
- Phenotype and proliferation characteristics of cultured spindle-shaped cells obtained from normal human skin and lesions of dermatofibroma, Kaposi's sarcoma, and dermatofibrosarcoma protuberans : a comparison with fibroblast and endothelial cells of the d
- Cutaneous dendritic cells in the crossfire between innate and adaptive immunity